Live Breaking News & Updates on Samera srour

Stay informed with the latest breaking news from Samera srour on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Samera srour and stay connected to the pulse of your community

Dr Srour on the Ongoing Investigation of CAR T-Cell Therapy in Advanced RCC

Samer A. Srour, MB ChB, MS, discusses the investigation of the allogeneic CAR T-cell therapy CTX131 in advanced clear cell renal cell carcinoma.

Texas , United-states , Samera-srour , Division-of-cancer-medicine , Department-of-stem-cell-transplantation , University-of-texas-md-anderson-cancer-center , Stem-cell-transplantation , Cellular-therapy , Cancer-medicine , Cancer-center , He-university-of-texas-md-anderson-cancer-center

Insider Insights: Unveiling Takeaways from AACR 2024

Experts from across the oncology field highlight their biggest takeaways and the hottest topics from the 2024 AACR Annual Meeting.

Texas , United-states , Karan-maxwell , Katharina-hoebel , Samera-srour , Michaelr-migden , Scott-kopetz , Erics-christenson , Jameel-muzaffar , Rebecca-porter , University-of-texas-md-anderson-cancer-center , Johns-hopkins-school-of-medicine

Insider Insights: Unveiling Takeaways from AACR 2024

Experts from across the oncology field highlight their biggest takeaways and the hottest topics from the 2024 AACR Annual Meeting.

Texas , United-states , Rebecca-porter , Jameel-muzaffar , Erics-christenson , Karan-maxwell , Katharina-hoebel , Samera-srour , Michaelr-migden , Scott-kopetz , Dana-farber-cancer-institute , University-of-texas-md-anderson-cancer-center

Dr Srour on the Safety and Efficacy of the Allogeneic CAR T-Cell Therapy CTX130 in Advanced ccRCC

Samer A. Srour, MB ChB, MS, discusses efficacy and safety data for the allogeneic CAR T-cell therapy CTX130 in advanced clear cell renal cell carcinoma.

Texas , United-states , Samera-srour , University-of-texas-md-anderson-cancer-center , Department-of-stem-cell-transplantation , Division-of-cancer-medicine , Stem-cell-transplantation , Cancer-medicine , Cancer-center , B-chb , S

CTX130 Provides Disease Control and Manageable Safety in Advanced ccRCC

The anti-CD70 CAR T-cell therapy CTX130 showed activity and manageable toxicities in advanced renal cell carcinoma.

Texas , United-states , San-diego , California , Houston , Samera-srour , International-metastatic-renal-cell-carcinoma-database-consortium , Division-of-cancer-medicine , University-of-texas-md-anderson-cancer-center , Department-of-stem-cell-transplantation , Cancer-discovery

Orca-Q Showcases Early Efficacy, Acceptable Safety in Haploidentical Stem Cell Transplant Without PTCy

The high-precision cellular product Orca-Q demonstrated early signals of clinical activity as well as an acceptable safety profile for patients undergoing haploidentical stem cell transplantation without posttransplant cyclophosphamide.

Texas , United-states , Sacramento , California , Houston , American , States-srour , Samera-srour , Department-of-stem-cell-transplantation , University-of-texas-md-anderson-cancer-center , Division-of-cancer-medicine

Novel Drug Has Survival Benefit in Stem Cell Transplant-Related GVHD

A novel cell therapy demonstrated early efficacy and an acceptable safety profile in patients with graft-versus-host disease undergoing haploidentical stem cell transplantation.

Texas , United-states , Houston , Samera-srour , University-of-texas-md-anderson-cancer-center , Cancer-center , News , Conference , Leukemia , Lymphoma , Myeloma

Dr Srour on Next Steps Planned for the Investigation of ALLO-316 in Advanced Clear Cell RCC

Samer A. Srour, MB ChB, MS, discusses planned next steps and future avenues of investigation for the novel CD70-targeted agent ALLO-316 in patients with advanced or metastatic clear cell renal cell carcinoma.

Texas , United-states , Samera-srour , Department-of-stem-cell-transplantation , Division-of-cancer-medicine , University-of-texas-md-anderson-cancer-center , Stem-cell-transplantation , Cellular-therapy , Cancer-medicine , Cancer-center , The-university-of-texas-md-anderson-cancer-center

Dr Srour on the Mechanism of Action of ALLO-316 in Metastatic Clear Cell RCC

Samer A. Srour, MB ChB, MS, discusses the mechanism of action of ALLO-316, which is being investigated for the treatment of patients with advanced or metastatic clear cell renal cell carcinoma, and details safety findings from the phase 1 TRAVERSE study evaluating ALLO-316 in this patient population.

Texas , United-states , Samera-srour , Department-of-stem-cell-transplantation , University-of-texas-md-anderson-cancer-center , Division-of-cancer-medicine , Stem-cell-transplantation , Cellular-therapy , Cancer-medicine , Cancer-center , The-university-of-texas-md-anderson-cancer-center

TRAVERSE Study Shows Preliminary Efficacy and Safety of ALLO-316 in Advanced Clear Cell RCC

Samer A. Srour, MB ChB, MS, explains the unique construction of ALLO-316, the potential for ALLO-316 to address an unmet need in patients with clear cell renal cell carcinoma, and how early data from the TRAVERSE study support the continued investigation of ALLO-316 in patients with CD70-expressing tumors.

Texas , United-states , Houston , Orrs , Samera-srour , University-of-texas-md-anderson-cancer-center , Department-of-stem-cell-transplantation , Division-of-cancer-medicine , Stem-cell-transplantation , Cellular-therapy , Cancer-medicine